Navidea Biopharmaceuticals (NAVB)

Navidea (NAVB) Financial Statements


Navidea Financial Overview

Navidea's market cap is currently ―. The company's EPS TTM is $-0.284; its P/E ratio is -0.34; Navidea is scheduled to report earnings on November 8, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue--$ 610.00$ 7.52K$ 6.52K
Gross Profit--$ -49.43K$ -126.92K$ 6.05K
EBIT$ -1.23M$ 2.41M$ -3.24M$ -4.95M$ -2.92M
EBITDA$ -1.09M$ 2.38M$ -3.29M$ -4.93M$ -2.90M
Net Income Common Stockholders$ 5.82M$ 3.37M$ -3.48M$ -7.75M$ -3.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.14M$ 33.80K$ 2.00M$ 4.60M$ 328.01K
Total Assets$ 8.22M$ 2.37M$ 4.37M$ 6.26M$ 2.50M
Total Debt$ 1.34M$ 354.37K$ 2.44M$ 1.82M$ 840.78K
Net Debt$ -4.81M$ 320.58K$ 439.76K$ -2.78M$ 512.76K
Total Liabilities$ 9.01M$ 11.92M$ 12.51M$ 10.93M$ 6.74M
Stockholders Equity$ -1.08M$ -9.84M$ -8.44M$ -4.96M$ -4.53M
Cash Flow-
Free Cash Flow$ 4.63M$ -1.76M$ -2.51M$ -1.94M$ -2.26M
Operating Cash Flow$ 4.69M$ -1.72M$ -2.43M$ -1.86M$ -2.14M
Investing Cash Flow$ -65.00K$ -39.41K$ -72.04K$ -78.93K$ -121.19K
Financing Cash Flow$ 1.48M$ -200.54K$ -99.76K$ 6.21M$ 1.37M
Currency in USD

Navidea Earnings and Revenue History

Navidea Debt to Assets

Navidea Cash Flow

Navidea Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis